Overview of Methodological Quality of Systematic Reviews about Gastric Cancer Risk and Protective Factors

被引:26
作者
Li, Lun [1 ,2 ]
Ying, Xiang-Ji [1 ,3 ]
Sun, Tian-Tian [4 ]
Yi, Kang [1 ,2 ]
Tian, Hong-Liang [1 ,2 ]
Sun, Rao [1 ]
Tian, Jin-Hui [1 ]
Yang, Ke-Hu [1 ,2 ]
机构
[1] Lanzhou Univ, Evidence Based Med Ctr, Sch Basic Med Sci, Lanzhou 730000, Peoples R China
[2] Lanzhou Univ, Clin Coll 1, Lanzhou 730000, Peoples R China
[3] Lanzhou Univ, Clin Coll 2, Lanzhou 730000, Peoples R China
[4] Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Shanghai 200030, Peoples R China
关键词
Stomach neoplasms; etiology; environmental exposure; Helicobacter pylori; systematic reviews; HELICOBACTER-PYLORI INFECTION; EPIDEMIOLOGIC EVIDENCE; TOBACCO SMOKING; STOMACH-CANCER; ALCOHOL-CONSUMPTION; MEASUREMENT TOOL; GREEN TEA; OCCUPATIONAL-EXPOSURE; VEGETABLE CONSUMPTION; KOREAN POPULATIONS;
D O I
10.7314/APJCP.2012.13.5.2069
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and Objective: A comprehensive overall review of gastric cancer (GC) risk and protective factors is a high priority, so we conducted the present study. Methods: Systematic searches in common medical electronic databases along with reference tracking were conducted to include all kinds of systematic reviews (SRs) about GC risk and protective factors. Two authors independently selected studies, extracted data, and evaluated the methodological qualities and the quality of evidence using R-AMSTAR and GRADE approaches. Results: Betacarotene below 20 mg/day, fruit, vegetables, non-fermented soy-foods, whole-grain, and dairy product were GC protective factors, while beta-carotene 20 mg/day or above, pickled vegetables, fermented soy-foods, processed meat 30g/d or above, or salty foods, exposure to alcohol or smoking, occupational exposure to Pb, overweight and obesity, helicobacter pylori infection were GC risk factors. So we suggested screening and treating H. pylori infection, limiting the amount of food containing risk factors (processed meat consumption, beta-carotene, pickled vegetables, fermented soy-foods, salty foods, alcohol), stopping smoking, avoiding excessive weight gain, avoidance of Pb, and increasing the quantity of food containing protective components (fresh fruit and vegetables, non-fermented soy-foods, whole-grain, dairy products). Conclusions: The conclusions and recommendations of our study were limited by including SRs with poor methodological bases and low quality of evidence, so that more research applying checklists about assessing the methodological qualities and reporting are needed for the future.
引用
收藏
页码:2069 / 2079
页数:11
相关论文
共 96 条
[1]  
An Ning An Ning, 2007, Journal of Shandong University (Health Sciences), V45, P423
[2]  
Anne P, 2009, IS HIGHLY SENSITIVE
[3]  
[Anonymous], 2017, The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses
[4]   Citrus fruit intake and stomach cancer risk: a quantitative systematic review [J].
Bae, Jong-Myon ;
Lee, Eun Ja ;
Guyatt, Gordon .
GASTRIC CANCER, 2008, 11 (01) :23-32
[5]   A meta-analysis of alcohol drinking and cancer risk [J].
Bagnardi, V ;
Blangiardo, M ;
La Vecchia, C ;
Corrao, G .
BRITISH JOURNAL OF CANCER, 2001, 85 (11) :1700-1705
[6]  
Bagnardi V, 2001, ALCOHOL RES HEALTH, V25, P263
[7]   GRADE guidelines: 3. Rating the quality of evidence [J].
Balshem, Howard ;
Helfand, Mark ;
Schuenemann, Holger J. ;
Oxman, Andrew D. ;
Kunz, Regina ;
Brozek, Jan ;
Vist, Gunn E. ;
Falck-Ytter, Yngve ;
Meerpohl, Joerg ;
Norris, Susan ;
Guyatt, Gordon H. .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2011, 64 (04) :401-406
[8]  
Bjelakovic Goran, 2008, Cochrane Database Syst Rev, pCD004183, DOI 10.1002/14651858.CD004183.pub3
[9]   Green tea (Camellia sinensis) for the prevention of cancer [J].
Boehm, Katja ;
Borrelli, Francesca ;
Ernst, Edzard ;
Habacher, Gabi ;
Hung, Shao Kang ;
Milazzo, Stefania ;
Horneber, Markus .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2009, (03)
[10]   Systematic review: green tea and gastrointestinal cancer risk [J].
Borrelli, F ;
Capasso, R ;
Russo, A ;
Ernst, E .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 19 (05) :497-510